Mitrofanoff principle
Mitrofanoff principle is a surgical procedure used to create a conduit, or channel, in the body. This conduit is typically used to drain urine from the bladder when normal urination is not possible or desirable. The procedure is named after the French surgeon who first described it, Paul Mitrofanoff.
History[edit | edit source]
The Mitrofanoff principle was first described in 1980 by French surgeon Paul Mitrofanoff. It was initially used in pediatric patients who were unable to perform clean intermittent catheterization (CIC) through the urethra. Since then, the procedure has been adapted for use in adults and is now a common surgical option for a variety of urological conditions.
Procedure[edit | edit source]
The Mitrofanoff procedure involves the creation of a conduit, or channel, from the skin surface to the bladder. This is typically done using a section of the patient's own intestine, although other tissues can also be used. The conduit is designed to be non-refluxing, meaning that urine can flow out of the bladder but cannot flow back in. This is achieved by implanting the conduit at an angle into the bladder wall, creating a valve-like effect.
Indications[edit | edit source]
The Mitrofanoff procedure is indicated for patients who are unable to perform clean intermittent catheterization (CIC) through the urethra. This may be due to physical limitations, such as poor hand function or obesity, or due to anatomical or surgical reasons, such as a narrow or absent urethra. The procedure may also be indicated for patients who prefer not to perform CIC through the urethra for personal or psychological reasons.
Complications[edit | edit source]
As with any surgical procedure, the Mitrofanoff procedure carries some risk of complications. These may include infection, bleeding, and complications related to general anesthesia. Specific to the Mitrofanoff procedure, there is a risk of conduit stenosis (narrowing), conduit leakage, and bladder stones. Regular follow-up with a urologist is required to monitor for these potential complications.
See also[edit | edit source]
| Mitrofanoff principle Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
